Diagnostic criteria for the Guillain-Barré syndrome: An analysis of 50 cases

https://doi.org/10.1016/0022-510X(71)90010-4Get rights and content

Abstract

The clinical features of 50 cases of Guillain-Barré Syndrome (GBS) are described and compared to previous series in an attempt to further refine the definition of the syndrome.

Nineteen of 50 patients (38%) were Negro. This was not significantly different from the 45.6% of Negroes seen among 3100 neurology patients admitted over this period. There would then seem to be little evidence for any selection by race.

Ten of 20 patients with a history of antecedent illness developed cranial neuropathies and only 3 of the 13 with cranial neuropathy had no history of preceding illness.

Mode of spread was most commonly ascending. Spread within the limbs initially affected with no ascending spread to other body parts was the next most common variety. Descending spread was uncommon. In about 20% of cases no spread occurred outside muscle groups initially affected.

Combined involvement of the proximal and distal muscles was the predominant type of muscle weakness and in most of these patients the proximal and distal muscles were about equally involved.

The occurrence of the GBS in the form of a pure motor polyneuropathy is emphasized. The presence of trunk muscle involvement or selective muscle involvement is also considered to represent a valuable clue to diagnosis.

Absent abdominal and cremasteric reflexes were found to be a common manifestation of the syndrome.

Sensory disturbances lasted longer than 2 months in 11 cases and in 4 of the 11 persisted longer than 6 months. Proprioceptive deficits were the more severe and persisted longer.

In 2 cases in the study elevations of the CSF protein first occurred 6 and 8 weeks respectively after the onset of the illness. No single pattern of protein elevation is characteristic of GBS; varying patterns of protein rise, fall, or plateau over time can occur.

Since 1962 there have been only 3 cases with respiratory involvement and none since 1967 as compared to 8 prior to 1962. Between the years 1952 and 1961, 9 out of 18 cases had cranial nerve involvement as compared to only 4 of 32 between 1962 and 1970 and 1 out of 19 since 1967. There has thus been a decreasing incidence over time of both cranial neuropathy and of the overall severity of the illness in this series.

Using respiratory insufficiency as a criterion for severe involvement, the severity of the illness was significantly correlated with the presence of cranial nerve involvement.

Diagnostic criteria for the GBS favoring a more comprehensive definition than any previously suggested are proposed.

References (29)

  • R.D. Adams

    Acute idiopathic polyneuritis

  • A. Berglund

    Polyradikulonevriter

    Nord. Med.

    (1954)
  • L.van Bogaert et al.

    Essai sur un groupe épidémique de cas de poly-radiculonévrite avec dissociation albumino-cytologique du liquide céphalo-rachidien (type de Guillain et Barré), chez l'enfant et chez l'adulte

    J. belge Neurol. Psychiat.

    (1938)
  • B. Bornstein

    Considerations on the Guillain-Barré syndrome

  • B. Boshes et al.

    Variability of the course of Guillain-Barré syndrome

    Neurology (Minneap.)

    (1953)
  • J.R. Brown et al.

    The diagnosis of Guillain-Barré's disease

    Amer. J. Med.

    (1947)
  • R.A. Coirault et al.

    Le Syndrome de Guillain-Barré

    (1958)
  • R.L. Debré et al.

    Remarques sur le syndrome de Guillain-Barré chez l'enfant (à propos de 32 observations personelles)

    Arch. franç. Pédiat.

    (1951)
  • R.M. Eiben et al.

    Recognition, prognosis and treatment of the Guillain-Barré syndrome

    Med. Clin. N. Amer.

    (1963)
  • M. Fisher

    An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)

    New Engl. J. Med.

    (1956)
  • F.M. Forster et al.

    Polyneuritis with facial diplegia

    New Engl. J. Med.

    (1941)
  • G. Guillain

    Radiculoneuritis with acellular hyperalbuminosis of the cerebrospinal fluid

    Arch. Neurol. Psychiat. (Chic.)

    (1936)
  • G. Guillain et al.

    Sur un syndrome de radiculonévrite avec hyperalbuminase du liquide céphalo-rachidien sans réaction cellulaire: Remarques sur les caractères cliniques et graphiques des réflexes tendineux

    Bull. Soc. Méd. Hôp. Paris

    (1916)
  • W. Haymaker et al.

    The Landry-Guillain-Barré syndrome

    Medicine (Baltimore)

    (1949)
  • Cited by (80)

    • Hemiparetic Guillain-Barré syndrome

      2016, Journal of the Neurological Sciences
    • Guillain-Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

      2011, Vaccine
      Citation Excerpt :

      This is particularly relevant for surveillance of GBS as an adverse event following new vaccines against chronic diseases (e.g. diabetes mellitus, rheumatoid arthritis); therapeutic vaccines (e.g. tumor vaccines); and genetically engineered vaccines, mucosal vaccines, or vaccines with slow-release delivery systems, all of which may require different standards. The Working Group recognizes that other criteria, case definitions, and recommendations for categorization of GBS and FS exist, both in peer-reviewed literature and in other formats [72–75]. Case definitions will differ based upon currently available data, intended use, and the clinical setting to which the case definition is to be applied.

    • Impairment of taste in the Guillain-Barré syndrome

      1990, Clinical Neurology and Neurosurgery
    View all citing articles on Scopus
    View full text